Taken together with a previous report indicating that the SHH pathway mediated renal fibrosis in mice after UUO and ischemia-reperfusion injury [32], our results suggested that SHH pathway activation was associated with disease progression in CKD patients, and that SHH inhibition could provide an additional therapeutic approach for progressive renal disease. This evidence concerns the gene SHH and chronic kidney disease.